The Role of Cathepsin X in Infection With the Helicobacter Pylori
NCT01137942 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 14
Last updated 2010-07-12
Summary
The immune response to Helicobacter pylori (Hp) importantly determines the pathogenesis of infection as well as the success of antibiotic eradication of the bacteria. The investigators want to demonstrate the importance of cathepsin X (CTSX), a cysteine protease, for the Hp eradication success. The diversity of the innate immune response to H. pylori antigens leading to either successful eradication of the infection or maintenance of chronic inflammation is connected to CTSX. The aim of this study is to determine whether H. pylori suppresses the CTSX expression and cytokine secretion in macrophage cell line THP-1 in the individuals that are not capable of eradicating the infection, opposite to H pylori in patients with successful H pylori eradication . The investigators also investigate the possibility whether strain-dependent differences in H. pylori lipopolysaccharide (LPS) influence the CTSX expression and cytokine secretion.
Conditions
- Persistence of Infection With Helicobacter Pylori
Interventions
- DRUG
-
clarithromycin, metronidazole, proton pump inhibitor
appropriate dose of antibiotics and proton pump inhibitor
Sponsors & Collaborators
-
University Medical Centre Ljubljana
lead OTHER
Principal Investigators
-
Alojz Ihan, MD, PhD · Institute of microbiology and immunology, Ljubljana, Slovenia
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-11-30
- Primary Completion
- 2009-12-31
- Completion
- 2010-07-31
Countries
- Slovenia
Study Locations
More Related Trials
-
Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli
NCT04764500 ·Status: ACTIVE_NOT_RECRUITING
-
One Sequencing Find All for Helicobacter Pylori Infection
NCT03837990 ·Status: UNKNOWN
-
Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
NCT00573521 ·Status: COMPLETED
-
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
NCT00275327 ·Status: COMPLETED
-
Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis
NCT05674032 ·Status: UNKNOWN
-
Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)
NCT00769171 ·Status: COMPLETED ·Phase: PHASE3
-
Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal Infections
NCT01155739 ·Status: COMPLETED
-
Ertapenem in Patients With Urosepsis
NCT03859362 ·Status: UNKNOWN ·Phase: PHASE4
-
Concentration of Ertapenem in Colorectal Tissue
NCT00535652 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Antimicrobial Effectiveness of CHG/IPA
NCT04035161 ·Status: COMPLETED
-
A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
NCT00952796 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection
NCT01721408 ·Status: COMPLETED ·Phase: PHASE4
-
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
NCT01381562 ·Status: TERMINATED ·Phase: PHASE2
-
Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments
NCT01703299 ·Status: COMPLETED
-
Risk Factors for Pyogenic Liver Abscess With Carbapenem-resistant Klebsiella Pneumoniae: A Matched Case-control Study
NCT05521139 ·Status: COMPLETED
-
Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections
NCT00752219 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects
NCT00081744 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of H.Pylori Eradication on Microbiome
NCT03231332 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region
NCT02803710 ·Status: UNKNOWN
-
Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis
NCT03179384 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli
NCT01820793 ·Status: TERMINATED ·Phase: NA
-
Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis
NCT01841411 ·Status: UNKNOWN ·Phase: PHASE4
-
Helicobacter Pylori Prevalence in Southern Region of Romania
NCT05874960 ·Status: COMPLETED
-
European Registry on the Management of Helicobacter Pylori Infection
NCT02328131 ·Status: RECRUITING
-
Biofilms on Short-term Indwelling Ureteral Stents
NCT02845726 ·Status: COMPLETED